Abstract
The effects of intravenous norepinephrine infusion (0.5 mg/kg in two hours) in conscious dogs can be classified according to the influence of pretreatment with phenoxybenzamine (2 or 5 mg/kg intravenously one hour before norepinephrine) or isopropylmethoxamine (BW 61-43) (8 mg/kg intravenously 20 to 30 minutes before infusion). Effects blocked or reduced by phenoxybenzamine, but not by BW 61-43, include the rise in arterial pressure, electrocardiographic changes, accumulation of pericardial fluid rich in lactic dehydrogenase, the rise in hematocrit, presence of inclusion bodies in liver cells, and necrosis of the adrenal cortex. Effects blocked by BW 61-43, but not by phenoxybenzamine, include the rises in plasma FFA and glucose and the accumulation of triglycerides in liver. Both phenoxybenzamine and BW 61-43 block, at least partially, the accumulation of triglycerides in heart. Neither phenoxybenzamine nor BW 61-43 prevents the norepinephrine-induced depletion of glycogen in liver.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Naunyn-Schmiedebergs Archiv f�r Experimentelle Pathologie und Pharmakologie
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
